Lipella Pharmaceuticals, Inc. (LIPO) Financial Statements
Lipella Pharmaceuticals, Inc. Financial Overview
Lipella Pharmaceuticals, Inc.'s market cap is currently $2.77K. The company's EPS TTM is $-2.60; its P/E ratio is -0.00; Lipella Pharmaceuticals, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Mar 23 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 536.36K | $ 449.62K | $ 184.16K | $ 259.35K | $ 961.68K |
| Gross Profit | $ -3.08M | $ -2.59M | $ -2.36M | $ -1.20M | $ -14.28K |
| Operating Income | $ -5.08M | $ -4.75M | $ -2.59M | $ -1.92M | $ -56.86K |
| EBITDA | $ -5.01M | $ -4.61M | $ -2.59M | $ -1.86M | $ -53.69K |
| Net Income | $ -5.02M | $ -4.62M | $ -2.60M | $ -1.87M | $ -61.66K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.18M | $ 3.29M | $ 5.12M | $ 1.71M | $ 606.74K |
| Total Assets | $ 2.67M | $ 3.58M | $ 5.95M | $ 2.01M | $ 955.02K |
| Total Debt | $ 47.60K | $ 136.59K | $ 429.52K | $ 282.96K | $ 388.91K |
| Net Debt | $ -2.14M | $ -3.16M | $ -4.69M | $ -1.13M | $ -217.82K |
| Total Liabilities | $ 754.42K | $ 432.73K | $ 1.27M | $ 589.34K | $ 491.70K |
| Stockholders' Equity | $ 1.92M | $ 3.14M | $ 4.68M | $ 1.42M | $ 463.32K |
| Cash Flow | |||||
| Free Cash Flow | $ -3.95M | $ -3.16M | $ -1.83M | $ -989.27K | $ -28.58K |
| Operating Cash Flow | $ -3.95M | $ -3.15M | $ -1.83M | $ -989.27K | $ -28.58K |
| Investing Cash Flow | $ 0.00 | $ -14.43K | $ 300.55K | $ -300.55K | $ 0.00 |
| Financing Cash Flow | $ 2.84M | $ 1.34M | $ 5.24M | $ 2.10M | $ 609.31K |
Currency in USD
